![Jacques Mallet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacques Mallet
Président chez
VALERIO THERAPEUTICS
Profil
Jacques Mallet currently works at Valerio Therapeutics SA, as Chairman, Gamma-X Corporate Advisory, as Chairman, Evolva SA, as Director-Executive Board from 2009, NEUWAY Pharma GmbH, as Director, and Fournier-Majoie Foundation, as Director.
Dr. Mallet also formerly worked at Theraptosis SA, as Director-Supervisory Board, AlchiMedics SA, as Director, EvoNext Holdings SA, as Director, Isocell Nutra SAS, as Director, Auriga Partners SA, as Partner from 2010 to 2012, Technoflex SAS, as Member-Supervisory Board, and Sanofi, as VP-Portfolio Analytics & Corporate Strategy.
Postes actifs de Jacques Mallet
| Sociétés | Poste | Début |
|---|---|---|
| VALERIO THERAPEUTICS | Président | - |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Corporate Officer/Principal | 18/11/2009 |
Fournier-Majoie Foundation | Directeur/Membre du Conseil | - |
NEUWAY Pharma GmbH
 NEUWAY Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Jacques Mallet
| Sociétés | Poste | Fin |
|---|---|---|
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Directeur/Membre du Conseil | 31/12/2012 |
Theraptosis SA
 Theraptosis SA Pharmaceuticals: MajorHealth Technology Develops and manufactures various drugs for cancer and neurodegenerative diseases | Directeur/Membre du Conseil | 10/03/2010 |
| SANOFI | Corporate Officer/Principal | - |
Isocell SA
 Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Directeur/Membre du Conseil | - |
| TECHNOFLEX | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Finance |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Technoflex SAS
 Technoflex SAS Chemicals: Major DiversifiedProcess Industries Designs and produces flexible bags & components for injectable solutions | Process Industries |
Theraptosis SA
Theraptosis SA Pharmaceuticals: MajorHealth Technology Develops and manufactures various drugs for cancer and neurodegenerative diseases | Health Technology |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Commercial Services |
AlchiMedics SA
 AlchiMedics SA Chemicals: Major DiversifiedProcess Industries Specializes in electro grafting coating technologies | Process Industries |
Evolva Holding SA
 Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Isocell SA
Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Retail Trade |
NEUWAY Pharma GmbH
NEUWAY Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system diseases | Health Technology |
Fournier-Majoie Foundation |
